about
The genetic structure and history of Africans and African AmericansGenome-wide and fine-resolution association analysis of malaria in West AfricaVaccines for malaria: how close are we?Dermatophytosis among Schoolchildren in Three Eco-climatic Zones of MaliUnderstandings of genomic research in developing countries: a qualitative study of the views of MalariaGEN participants in Mali.Plasmodium vivax malaria in Mali: a study from three different regionsNew var reconstruction algorithm exposes high var sequence diversity in a single geographic location in MaliSafety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.Valid consent for genomic epidemiology in developing countriesImpact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult MaliansSafety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trialSafety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development.Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children.Engaging diverse communities participating in clinical trials: case examples from across Africa.Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in MaliFirst detection of Leishmania major DNA in Sergentomyia (Spelaeomyia) darlingi from cutaneous leishmaniasis foci in MaliStable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali.Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.Candidate polymorphisms and severe malaria in a Malian population.Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemiaA high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDaExtended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial.Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria.Preliminary study of the fungal ecology at the haematology and medical-oncology ward in Bamako, Mali.Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, MaliA field trial to assess a blood-stage malaria vaccine.Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women.Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, MaliNext generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite proteinNo evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosettingHemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children.Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implicationsExpression of complement and toll-like receptor pathway genes is associated with malaria severity in Mali: a pilot case control study.Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design.
P50
Q22065887-1466C5CF-4B6D-4EF7-A209-E728FE91C7B2Q24632119-C44606C8-FA74-4F8C-A292-43A06DD45605Q27024344-C39AED81-18BB-4BE0-B582-DFD7C7E0AF84Q27303683-5624EF89-5E4D-4AE2-B832-39DC528E7456Q28648360-12F0197C-3FEC-4669-AEC5-933EA9780F88Q28709948-2034AA13-E0A3-4E12-B27A-E98BA1470611Q30843121-C6AF506B-49F1-451B-8D5A-6C311DE37612Q33264523-26103684-4620-4E1E-B2A8-23D586A9E112Q33278087-61F44B03-4CBD-4B3E-9FE0-825558C86C66Q33282645-BEA841CC-90D4-478B-9B59-CE673E53D976Q33302903-9E5D9E2E-5CFA-487C-B3DE-CEEF35A37071Q33316023-F9CC6D54-C76B-4418-A1F8-6B32D70632C0Q33530106-B1D4E83C-75C0-4ACF-998E-1823BC416DB1Q33654911-AB1A8EB7-FB5D-4C48-955E-54AD86DD7D17Q33846126-13D46E7A-1EFD-401E-A2AD-C807933CBEEEQ33881768-7BFFD4DF-FC54-4C3F-A91E-3DA4BC14D3E2Q34010897-4C83B230-A552-4600-8B6A-89AC398D2760Q34083032-E286DC65-4702-4A49-A0C2-6D9C5A67B7D8Q34140111-4CEA6262-2469-407B-862F-53328B74A80AQ34271312-170896D5-955E-411D-AEC5-5321BE308544Q34398049-F86359DB-CB44-423D-9A7C-CAB2D5890514Q34401225-2EC689F8-D19C-4D2D-8472-9FDE88F30775Q34407989-BD95E097-818D-4B4C-BA19-2C44FCCDFFF4Q34568283-40D61660-6491-4F25-BCD5-916BE8B4BF20Q34602857-2E2DE721-4F2A-454C-9D59-9C0A74340CF5Q35048336-9CB1359D-D391-494F-B727-AE9DFFA7C0A4Q35140646-C1722ECC-CA2C-47D0-A407-2F984981B2EDQ35180217-6728CEE4-86F0-4486-BA57-9C8E1D82E0F2Q35616221-7B480849-6B05-43D4-A047-01AD82DC6147Q35622737-95AFB6EF-D65F-4A0A-B8D8-96A8DE7AB302Q35692513-35882937-90EE-4C07-A777-88000A76878BQ35865240-8D33D178-F87D-4AF1-B7E7-D1CC231D0EC7Q35910527-9CAFC489-B610-4463-9D20-CCAA33608377Q36080109-C6BCF3AC-C737-4328-BA82-6E0B64C743B1Q36141509-591D137E-627C-43EC-A0CD-D0A5B16C0957Q36250223-43E8CCE9-7A10-4C8C-A709-E34A1D2F2FC9Q36304234-3F7F3055-9EF8-4F76-88F6-8BCF6D8BC2A1Q36509831-4DF260EB-615C-43CE-901B-EAE66576DD4DQ36667901-EFBAE5F8-5044-463F-AE42-85CAA0FCA436Q36693957-626092BE-6AE4-42EB-9CC8-7099F0225D45
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mahamadou A Thera
@nl
Mahamadou A Thera
@sl
Mahamadou A. Thera
@en
Mahamadou A. Thera
@es
type
label
Mahamadou A Thera
@nl
Mahamadou A Thera
@sl
Mahamadou A. Thera
@en
Mahamadou A. Thera
@es
prefLabel
Mahamadou A Thera
@nl
Mahamadou A Thera
@sl
Mahamadou A. Thera
@en
Mahamadou A. Thera
@es
P106
P1153
57196904325
P21
P31
P496
0000-0002-2679-035X